Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 115,000 shares, a growth of 142.6% from the November 15th total of 47,400 shares. Based on an average daily volume of 653,700 shares, the short-interest ratio is currently 0.2 days. Currently, 0.2% of the shares of the stock are short sold.
Eterna Therapeutics Stock Down 1.8 %
Shares of Eterna Therapeutics stock traded down $0.01 during mid-day trading on Wednesday, reaching $0.32. 265,434 shares of the stock traded hands, compared to its average volume of 185,853. The business has a 50-day moving average of $0.83 and a 200 day moving average of $1.43. The stock has a market capitalization of $1.75 million, a PE ratio of -0.04 and a beta of 4.19. Eterna Therapeutics has a fifty-two week low of $0.27 and a fifty-two week high of $2.63.
Eterna Therapeutics Company Profile
Read More
- Five stocks we like better than Eterna Therapeutics
- Best Aerospace Stocks Investing
- The Great CPU Race: AMD and Intel Battle for Dominance
- Why is the Ex-Dividend Date Significant to Investors?
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Utilities Stocks Explained – How and Why to Invest in Utilities
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Eterna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eterna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.